Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) – Equities research analysts at Cantor Fitzgerald issued their FY2024 earnings estimates for shares of Aurinia Pharmaceuticals in a report issued on Tuesday, July 11th. Cantor Fitzgerald analyst O. Brayer forecasts that the biotechnology company will post earnings of ($0.39) per share for the year. The consensus […]